Soft tissue manipulation in patients with restricted mouth opening.

Effectiveness of soft tissue manipulation on function & muscle activity of superficial masseter and anterior temporalis in patients with oral submucous fibrosis.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/054716

Enrollment

Registered

2023-07-04

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K135- Oral submucous fibrosis

Interventions

Intervention1: Soft tissue manipulation and intralesional injections: Group 1 (Soft tissue manipulation + intralesional medications) Group 2 (Intralesional medications) Soft Tissue Manipulation (MFR +

Eligibility

Inclusion criteria

Inclusion criteria: Individuals with OSMF. Both male and female participants

Exclusion criteria

Exclusion criteria: Patients with infections and inflammatory causes responsible for trismus. Trauma to the maxillofacial skeleton. Dermatomyositis Scleroderma. Gingivitis and periodontitis. Parafunctional habits. Patients who are unable to give consent.

Design outcomes

Primary

Measure	Time frame
Mouth Opening FunctionTimepoint: Baseline 3 weeks 6 weeks	—

Secondary

Measure	Time frame
EMGTimepoint: Baseline 3 weeks 6 weeks;NPRSTimepoint: Baseline 3 weeks 6 weeks	—

Countries

India

Contacts

Public ContactRohan Kumar Sahu

Maharishi Markandeshwar Institute of Physiotherapy and Rehabilitation.

manugoyal1111@gmail.com8307715320

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026